Sorry, there are no transactions available for this individual.
Deciphera Pharmaceuticals Inc.
NAS: DCPH
/marketstate/country/us
/zigman2/quotes/203556943/composite
After Hours
--Quotes are delayed by 20 min
Jan 27, 2023, 4:23 p.m.
$
17.56
Change
+0.25 +1.44%
Volume
Volume 8,535
Quotes are delayed by 20 min
/zigman2/quotes/203556943/composite
Previous close
$ 17.98
$ 17.31
Change
-0.67 -3.73%
Day low
Day high
$17.22
$18.08
52 week low
52 week high
$6.51
$22.76
Officers and Executives
|
Mr. Steven L. Hoerter President & Chief Executive Officer |
|
Mr. Thomas P. Kelly Chief Financial Officer, Treasurer & Executive VP |
|
Dr. Matthew L. Sherman Chief Medical Officer & Executive Vice President |
|
Dr. Rodrigo Ruiz Soto Senior Vice President-Clinical Development |
|
Dr. Daniel L. Flynn Chief Scientific Officer & Executive VP |
|
Dr. Stephen B. Ruddy Chief Technical Officer & SVP |
|
Ms. Kelley Dealhoy Chief Business Officer & Senior Vice President |
|
Mr. Daniel C. Martin Chief Commercial Officer & SVP |
|
Ms. Lisa Amaya Price Chief Human Resources Officer & Senior VP |
|
Mr. Jeffrey M. Held General Counsel & Senior Vice President |
|
Mr. Jama Pitman Vice President-Regulatory & Quality Assurance |
|
Dr. James A. Bristol Chairman |
|
Dr. Susan L. Kelley Independent Director |
|
Mr. Ron Squarer Independent Director |
|
Mr. Franklin S. Friedman Independent Director |
|
Ms. Patricia L. Allen Independent Director |
|
Dr. Edward J. Benz Independent Director |
|
Mr. John R. Martin Independent Director |
|
Mr. Dennis L. Walsh Independent Director |
Log In
8:36 AM EST
January 28, 2023
/marketstate/country/us
New York
Closed
/marketstate/country/uk
London
Closed
/marketstate/country/jp
Tokyo
Closed
/marketstate/country/us
/marketstate/country/uk
/marketstate/country/jp
Latest News
-
/news/latest
-
The S&P 500 is trying to top 4100, and the odds favor that happening by the end of January.
-
Twitter co-founder: Elon Musk ‘doesn’t seem like’ a good person to run the company
-
Fed set to deliver quarter-point rate hike along with ‘one last hawkish sting in the tail’
-
This dividend-stock ETF has a 12% yield and is beating the S&P 500 by a substantial amount
-
S&P 500 nears first ‘golden cross’ in 2½ years, but this doesn’t guarantee more gains ahead
-
U.S. stocks end higher, tech-heavy Nasdaq scores fourth straight week of gains as Fed meeting looms
-
Fed rejects crypto bank’s application to join U.S. payment system
-
French nun Sister André — the world’s oldest person — has died at 118
-
Chevron, Comcast, and 10 More Companies That Raised Their Dividends
-
Emerging Market Debt Is Hot. Further Gains Could Be Hard to Find.
-
Bed Bath & Beyond Says It Can't Pay Its Debts. Here's What Happens Next.
-
The Bulls Have It in 2023—and Last Year’s Losers Are Winners
- Loading more headlines...
Kiosk
-
13203972000001320598500000/conga/kiosk/alerts.html 310238
Alerts
-
13337034000001333949700000/conga/kiosk/games.html 310284
Virtual Stock Exchange
Our free stock-market game
• Trade your virtual portfolio in real time
• Talk strategies in group discussions
• Find or create a game that suits you
• Use our learning center to improve
Copyright © 2023 MarketWatch, Inc. All rights reserved.
Subscriber Agreement & Terms of Use |
Privacy Notice |
Cookie Notice
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.